Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Modified AdCTLA-4 vector blocks alloimmune response in vitro.

G Zamir1, A E Gelman, F Debonera

  • 1Department of Surgery, University of Pennsylvania, Philadelphia, Pennsylvania 19104, USA.

The Journal of Surgical Research
|May 9, 2001
PubMed
Summary

A novel adenoviral vector, AdCTLA-4ex-TAG, was developed to restrict immunosuppression to the liver graft. This vector effectively abrogated alloimmune responses in vitro and controlled extrahepatic tumor growth, suggesting localized immunosuppression for transplant therapy.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Two-stage surgery for large sacrococcygeal chordomas: How I do it.

Annales de chirurgie plastique et esthetique·2024
Same author

Acute diverticulitis with extraluminal air: is conservative treatment sufficient? A single-center retrospective study.

Techniques in coloproctology·2024
Same author

Endovascular therapies for hepatic artery stenosis post liver transplantation.

CVIR endovascular·2022
Same author

Splenic infarction complicated with abscess after pelvic trauma as the first presentation of patent foramen ovale - A case report.

Trauma case reports·2021
Same author

Immediate preoperative renal artery embolization in the resection of complex renal tumors (UroCCR-48 Reinbol study).

International urology and nephrology·2020
Same author

Impact of cirrhosis in patients undergoing laparoscopic liver resection in a nationwide multicentre survey.

The British journal of surgery·2020

Area of Science:

  • Immunology
  • Gene Therapy
  • Transplantation

Background:

  • Gene transfer of CTLA-4Ig for liver allografts causes systemic immunosuppression.
  • A novel adenoviral vector, AdCTLA-4ex-TAG, was engineered to limit immunosuppression locally.
  • This vector deletes the Ig sequence for rapid extrahepatic degradation while maintaining graft immunosuppression.

Purpose of the Study:

  • To develop a novel adenoviral vector for localized immunosuppression in liver allografts.
  • To assess the efficacy of AdCTLA-4ex-TAG in abrogating alloimmune responses.
  • To evaluate the extrahepatic effects of AdCTLA-4ex-TAG.

Main Methods:

  • Constructed AdCTLA-4ex-TAG by fusing CTLA-4ex to an epitope TAG.
  • Transfected MH(1)C(1) cells with AdCTLA-4ex-TAG and analyzed expression via Western blot.

Related Experiment Videos

  • Assessed in vitro alloimmune response using CFSE proliferation assay and extrahepatic effects by monitoring tumor growth in rats.

    • Main Results:

    • AdCTLA-4ex-TAG efficiently expressed and secreted the recombinant CTLA-4exTAG protein in vitro.
    • The supernatant from transfected cells abrogated alloimmune responses by diminishing CD4(+) T cell proliferation.
    • Liver-directed delivery of AdCTLA-4ex-TAG controlled extrahepatic tumor growth, indicating localized immunosuppression.

    Conclusions:

    • AdCTLA-4ex-TAG demonstrates efficient in vitro expression and retains immunosuppressive activity.
    • The vector effectively abrogates in vitro alloimmune responses.
    • Liver-directed delivery suggests AdCTLA-4ex-TAG provides localized immunosuppression, paving the way for transplant applications.